Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) plan to proceed with two studies of endorsements and financial disclosure. The researchers first proposed the research last January and addressed public comment about the research in a Federal Register notice. “Advertisers have used celebrity endorsers for years, and DTC pharmaceutical promotion is no di... Read More